329 related articles for article (PubMed ID: 31685649)
1. Activation of PPARγ Attenuates the Expression of Physical and Affective Nicotine Withdrawal Symptoms through Mechanisms Involving Amygdala and Hippocampus Neurotransmission.
Domi E; Caputi FF; Romualdi P; Domi A; Scuppa G; Candeletti S; Atkins A; Heilig M; Demopulos G; Gaitanaris G; Ciccocioppo R; Ubaldi M
J Neurosci; 2019 Dec; 39(49):9864-9875. PubMed ID: 31685649
[TBL] [Abstract][Full Text] [Related]
2. Genetic Deletion of Neuronal PPARγ Enhances the Emotional Response to Acute Stress and Exacerbates Anxiety: An Effect Reversed by Rescue of Amygdala PPARγ Function.
Domi E; Uhrig S; Soverchia L; Spanagel R; Hansson AC; Barbier E; Heilig M; Ciccocioppo R; Ubaldi M
J Neurosci; 2016 Dec; 36(50):12611-12623. PubMed ID: 27810934
[TBL] [Abstract][Full Text] [Related]
3. Further evidence for the involvement of the PPARγ system on alcohol intake and sensitivity in rodents.
Domi E; Domi A; Ubaldi M; Somaini L; Demopulos G; Gaitanaris G; Ciccocioppo R
Psychopharmacology (Berl); 2020 Oct; 237(10):2983-2992. PubMed ID: 32676772
[TBL] [Abstract][Full Text] [Related]
4. PPARγ activation attenuates opioid consumption and modulates mesolimbic dopamine transmission.
de Guglielmo G; Melis M; De Luca MA; Kallupi M; Li HW; Niswender K; Giordano A; Senzacqua M; Somaini L; Cippitelli A; Gaitanaris G; Demopulos G; Damadzic R; Tapocik J; Heilig M; Ciccocioppo R
Neuropsychopharmacology; 2015 Mar; 40(4):927-37. PubMed ID: 25311134
[TBL] [Abstract][Full Text] [Related]
5. Pioglitazone attenuates the opioid withdrawal and vulnerability to relapse to heroin seeking in rodents.
de Guglielmo G; Kallupi M; Scuppa G; Demopulos G; Gaitanaris G; Ciccocioppo R
Psychopharmacology (Berl); 2017 Jan; 234(2):223-234. PubMed ID: 27714428
[TBL] [Abstract][Full Text] [Related]
6. Differential behavioral and molecular alterations upon protracted abstinence from cocaine versus morphine, nicotine, THC and alcohol.
Becker JAJ; Kieffer BL; Le Merrer J
Addict Biol; 2017 Sep; 22(5):1205-1217. PubMed ID: 27126842
[TBL] [Abstract][Full Text] [Related]
7. Amygdala Arginine Vasopressin Modulates Chronic Ethanol Withdrawal Anxiety-Like Behavior in the Social Interaction Task.
Harper KM; Knapp DJ; Butler RK; Cook CA; Criswell HE; Stuber GD; Breese GR
Alcohol Clin Exp Res; 2019 Oct; 43(10):2134-2143. PubMed ID: 31386210
[TBL] [Abstract][Full Text] [Related]
8. Selective c-fos induction and decreased dopamine release in the central nucleus of amygdala in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome.
Panagis G; Hildebrand BE; Svensson TH; Nomikos GG
Synapse; 2000 Jan; 35(1):15-25. PubMed ID: 10579804
[TBL] [Abstract][Full Text] [Related]
9. The peroxisome proliferator activated receptor gamma agonist pioglitazone increases functional expression of the glutamate transporter excitatory amino acid transporter 2 (EAAT2) in human glioblastoma cells.
Ching J; Amiridis S; Stylli SS; Bjorksten AR; Kountouri N; Zheng T; Paradiso L; Luwor RB; Morokoff AP; O'Brien TJ; Kaye AH
Oncotarget; 2015 Aug; 6(25):21301-14. PubMed ID: 26046374
[TBL] [Abstract][Full Text] [Related]
10. Acute administration of pioglitazone attenuates morphine withdrawal syndrome in rat: a novel role of pioglitazone.
Ghavimi H; Azarfardian A; Maleki-Dizaji N; Hassanzadeh K; Ghanbarzadeh S; Charkhpour M
Drug Res (Stuttg); 2015 Mar; 65(3):113-8. PubMed ID: 24504689
[TBL] [Abstract][Full Text] [Related]
11. PPARγ agonism attenuates cocaine cue reactivity.
Miller WR; Fox RG; Stutz SJ; Lane SD; Denner L; Cunningham KA; Dineley KT
Addict Biol; 2018 Jan; 23(1):55-68. PubMed ID: 27862692
[TBL] [Abstract][Full Text] [Related]
12. Extended access to nicotine leads to a CRF1 receptor dependent increase in anxiety-like behavior and hyperalgesia in rats.
Cohen A; Treweek J; Edwards S; Leão RM; Schulteis G; Koob GF; George O
Addict Biol; 2015 Jan; 20(1):56-68. PubMed ID: 23869743
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor gamma activation relieves expression of behavioral sensitization to methamphetamine in mice.
Maeda T; Kiguchi N; Fukazawa Y; Yamamoto A; Ozaki M; Kishioka S
Neuropsychopharmacology; 2007 May; 32(5):1133-40. PubMed ID: 17019405
[TBL] [Abstract][Full Text] [Related]
14. Progressive modulation of accumbal neurotransmission and anxiety-like behavior following protracted nicotine withdrawal.
Morud J; Strandberg J; Andrén A; Ericson M; Söderpalm B; Adermark L
Neuropharmacology; 2018 Jan; 128():86-95. PubMed ID: 28986279
[TBL] [Abstract][Full Text] [Related]
15. Pioglitazone potentiates development of morphine-dependence in mice: possible role of NO/cGMP pathway.
Javadi S; Ejtemaeimehr S; Keyvanfar HR; Moghaddas P; Aminian A; Rajabzadeh A; Mani AR; Dehpour AR
Brain Res; 2013 May; 1510():22-37. PubMed ID: 23399681
[TBL] [Abstract][Full Text] [Related]
16. The "stop" and "go" of nicotine dependence: role of GABA and glutamate.
D'Souza MS; Markou A
Cold Spring Harb Perspect Med; 2013 Jun; 3(6):. PubMed ID: 23732855
[TBL] [Abstract][Full Text] [Related]
17. PPARγ activation blocks development and reduces established neuropathic pain in rats.
Morgenweck J; Griggs RB; Donahue RR; Zadina JE; Taylor BK
Neuropharmacology; 2013 Jul; 70():236-46. PubMed ID: 23415633
[TBL] [Abstract][Full Text] [Related]
18. GABA and opioid mechanisms of the central amygdala underlie the withdrawal-potentiated startle from acute morphine.
Cabral A; Ruggiero RN; Nobre MJ; Brandão ML; Castilho VM
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):334-44. PubMed ID: 19150477
[TBL] [Abstract][Full Text] [Related]
19. Effects of NPY and the specific Y1 receptor agonist [D-His(26)]-NPY on the deficit in brain reward function and somatic signs associated with nicotine withdrawal in rats.
Rylkova D; Boissoneault J; Isaac S; Prado M; Shah HP; Bruijnzeel AW
Neuropeptides; 2008 Jun; 42(3):215-27. PubMed ID: 18468678
[TBL] [Abstract][Full Text] [Related]
20. [Activation of PPARγ pathway enhances cellular anti-oxidant capacity to protect long-term cultured primary rat neural cells from apoptosis].
Wang H; Fan J; Chen W; Gao Z; Zhang G; Wu H; Yu X
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jan; 39(1):23-29. PubMed ID: 30692062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
